Related Experiment Videos
[HCG-producing intrahepatic cholangiocarcinoma]
Gan No Rinsho. Japan Journal of Cancer Clinics
|November 1, 1986
Summary
This case study reveals that intrahepatic cholangiocarcinoma can produce human chorionic gonadotropin (hCG). Elevated hCG levels correlated with tumor presence and recurrence in a male patient.
Area of Science:
- Oncology
- Endocrinology
Background:
- Intrahepatic cholangiocarcinoma is a rare primary liver cancer.
- Human chorionic gonadotropin (hCG) is typically associated with pregnancy but can be an ectopic marker in some cancers.
Observation:
- A 60-year-old male patient with intrahepatic cholangiocarcinoma presented with elevated serum hCG levels (44.6 mIU/ml).
- Following surgical resection (right hemihepatectomy), serum hCG normalized within 28 days.
- Tumor recurrence six months post-surgery led to a significant rise in hCG (268 mIU/ml).
Findings:
- Immunohistochemical analysis confirmed hCG-positive cells within the cholangiocarcinoma tissue.
- The study suggests intrahepatic cholangiocarcinoma as the source of ectopic hCG production and secretion.
- Serum hCG levels demonstrated a strong correlation with tumor burden and recurrence.
Implications:
- Ectopic hCG production by intrahepatic cholangiocarcinoma may serve as a potential tumor marker.
- Monitoring hCG levels could aid in early detection of recurrence in affected patients.
- This finding expands the understanding of non-seminomatous germ cell tumor markers in non-germ cell malignancies.